{
  "ptid_time": "021_S_0984_2010-12-03",
  "img_path": "/data/qiuhui/data/adni/images/021_S_0984/2010-12-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 103,131 mm³, 119.4% above the reference mean. With a Z-score of 3.47 (100.0th percentile), this represents profound enlargement; whole brain volume measures 1,065,200 mm³, 3.5% above the reference mean. With a Z-score of 0.46 (67.7th percentile), this represents normal volume . ",
  "text_data": "Age is 80.6 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. Medical history: Psychiatric; Cardiovascular; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Alcohol Abuse; Smoking. MMSE: 30.0. MoCA: 22.0. Logical Memory: 11.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.07 SUVR (normal ); Amyloid beta: 354.40 pg/mL (moderate reduced); Total tau: 358.20 pg/mL (mild elevated); Phosphorylated tau: 41.93 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound ventricular enlargement (Z-score 3.47), which is indicative of significant brain atrophy, despite normal whole brain volume. The MoCA score of 22 suggests mild cognitive impairment, while the MMSE of 30 is incongruent, possibly due to test limitations. Biomarkers (Aβ reduction, elevated P-tau) support Alzheimer’s pathology, but the normal AV45 (amyloid PET) complicates the picture.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology, but not yet meeting dementia criteria).  \n\n**Confidence:** **Medium** (due to conflicting biomarkers and cognitive scores).",
  "timestamp": "2025-07-26T01:35:58.121539"
}